APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cutting Biopsy System For Breast Lesion

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cutting Biopsy System For Breast Lesion Market Analysis and Forecast 2026-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchCutting Biopsy System For Breast Lesion Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Cutting Biopsy System For Breast Lesion Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Cutting Biopsy System For Breast Lesion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cutting Biopsy System For Breast Lesion Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cutting Biopsy System For Breast Lesion Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cutting Biopsy System For Breast Lesion market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cutting Biopsy System For Breast Lesion is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cutting Biopsy System For Breast Lesion is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cutting Biopsy System For Breast Lesion is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cutting Biopsy System For Breast Lesion is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cutting Biopsy System For Breast Lesion include BD, Danaher Corporation, Cultiva Medical, Chongqing Xishan Science & Technology and GMT Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cutting Biopsy System For Breast Lesion, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cutting Biopsy System For Breast Lesion, also provides the revenue of main regions and countries. Of the upcoming market potential for Cutting Biopsy System For Breast Lesion, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cutting Biopsy System For Breast Lesion revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cutting Biopsy System For Breast Lesion market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cutting Biopsy System For Breast Lesion revenue, projected growth trends, production technology, application and end-user industry.

Cutting Biopsy System For Breast Lesion Segment by Company

BD

Danaher Corporation

Cultiva Medical

Chongqing Xishan Science & Technology

GMT Medical

Cutting Biopsy System For Breast Lesion Segment by Type

Half Cut

Full Cut

Cutting Biopsy System For Breast Lesion Segment by Application

Malignant Breast Tumors

Benign Breast Tumors

Cutting Biopsy System For Breast Lesion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cutting Biopsy System For Breast Lesion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cutting Biopsy System For Breast Lesion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cutting Biopsy System For Breast Lesion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cutting Biopsy System For Breast Lesion in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cutting Biopsy System For Breast Lesion company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cutting Biopsy System For Breast Lesion revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Half Cut Major Player Table 3. Full Cut Major Player Table 4. Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Malignant Breast Tumors Major Player Table 6. Benign Breast Tumors Major Player Table 7. Cutting Biopsy System For Breast Lesion Industry Trends Table 8. Cutting Biopsy System For Breast Lesion Industry Drivers Table 9. Cutting Biopsy System For Breast Lesion Industry Opportunities and Challenges Table 10. Cutting Biopsy System For Breast Lesion Industry Restraints Table 11. Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Cutting Biopsy System For Breast Lesion Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Cutting Biopsy System For Breast Lesion Market Share by Region (2021-2026) Table 14. Global Cutting Biopsy System For Breast Lesion Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Cutting Biopsy System For Breast Lesion Market Share by Region (2027-2032) Table 16. Global Cutting Biopsy System For Breast Lesion Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Players (2021-2026) Table 18. Global Cutting Biopsy System For Breast Lesion Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cutting Biopsy System For Breast Lesion Key Players Headquarters & Area Served Table 20. Global Cutting Biopsy System For Breast Lesion Players, Product Type & Application Table 21. Global Cutting Biopsy System For Breast Lesion Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Cutting Biopsy System For Breast Lesion by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Cutting Biopsy System For Breast Lesion Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Type (2021-2026) Table 28. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Type (2027-2032) Table 29. Global Cutting Biopsy System For Breast Lesion Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Application (2021-2026) Table 33. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Application (2027-2032) Table 34. BD Company Information Table 35. BD Business Overview Table 36. BD Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. BD Cutting Biopsy System For Breast Lesion Product Portfolio Table 38. BD Recent Development Table 39. Danaher Corporation Company Information Table 40. Danaher Corporation Business Overview Table 41. Danaher Corporation Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Danaher Corporation Cutting Biopsy System For Breast Lesion Product Portfolio Table 43. Danaher Corporation Recent Development Table 44. Cultiva Medical Company Information Table 45. Cultiva Medical Business Overview Table 46. Cultiva Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Cultiva Medical Cutting Biopsy System For Breast Lesion Product Portfolio Table 48. Cultiva Medical Recent Development Table 49. Chongqing Xishan Science & Technology Company Information Table 50. Chongqing Xishan Science & Technology Business Overview Table 51. Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Product Portfolio Table 53. Chongqing Xishan Science & Technology Recent Development Table 54. GMT Medical Company Information Table 55. GMT Medical Business Overview Table 56. GMT Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. GMT Medical Cutting Biopsy System For Breast Lesion Product Portfolio Table 58. GMT Medical Recent Development Table 59. North America Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026) & (US$ Million) Table 60. North America Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032) & (US$ Million) Table 61. North America Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026) & (US$ Million) Table 62. North America Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032) & (US$ Million) Table 63. North America Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026) & (US$ Million) Table 65. North America Cutting Biopsy System For Breast Lesion Revenue by Country (US$ Million) & (2027-2032) Table 66. Europe Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026) & (US$ Million) Table 67. Europe Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032) & (US$ Million) Table 68. Europe Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026) & (US$ Million) Table 69. Europe Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032) & (US$ Million) Table 70. Europe Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026) & (US$ Million) Table 72. Europe Cutting Biopsy System For Breast Lesion Revenue by Country (US$ Million) & (2027-2032) Table 73. China Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026) & (US$ Million) Table 74. China Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032) & (US$ Million) Table 75. China Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026) & (US$ Million) Table 76. China Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032) & (US$ Million) Table 77. Asia Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026) & (US$ Million) Table 78. Asia Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032) & (US$ Million) Table 79. Asia Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026) & (US$ Million) Table 80. Asia Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia Cutting Biopsy System For Breast Lesion Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Cutting Biopsy System For Breast Lesion Revenue by Region (US$ Million) & (2021-2026) Table 83. Asia Cutting Biopsy System For Breast Lesion Revenue by Region (US$ Million) & (2027-2032) Table 84. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026) & (US$ Million) Table 85. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032) & (US$ Million) Table 86. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026) & (US$ Million) Table 87. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032) & (US$ Million) Table 88. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026) & (US$ Million) Table 90. SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country (US$ Million) & (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Cutting Biopsy System For Breast Lesion Image Figure 2. Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cutting Biopsy System For Breast Lesion Market Size Share 2021 VS 2025 VS 2032 Figure 4. Half Cut Image Figure 5. Full Cut Image Figure 6. Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cutting Biopsy System For Breast Lesion Market Size Share 2021 VS 2025 VS 2032 Figure 8. Malignant Breast Tumors Image Figure 9. Benign Breast Tumors Image Figure 10. Global Cutting Biopsy System For Breast Lesion Market Size (US$ Million) & (2021-2032) Figure 11. Global Cutting Biopsy System For Breast Lesion Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cutting Biopsy System For Breast Lesion Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Cutting Biopsy System For Breast Lesion Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Cutting Biopsy System For Breast Lesion Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cutting Biopsy System For Breast Lesion Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Type (2021-2032) Figure 18. Global Cutting Biopsy System For Breast Lesion Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Application (2021-2032) Figure 21. North America Cutting Biopsy System For Breast Lesion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032) Figure 23. North America Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032) Figure 24. North America Cutting Biopsy System For Breast Lesion Revenue Share by Country (2021-2032) Figure 25. United States Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Cutting Biopsy System For Breast Lesion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032) Figure 30. Europe Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032) Figure 31. Europe Cutting Biopsy System For Breast Lesion Revenue Share by Country (2021-2032) Figure 32. Germany Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Cutting Biopsy System For Breast Lesion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032) Figure 42. China Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032) Figure 43. Asia Cutting Biopsy System For Breast Lesion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032) Figure 45. Asia Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032) Figure 46. Asia Cutting Biopsy System For Breast Lesion Revenue Share by Region (2021-2032) Figure 47. Japan Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Cutting Biopsy System For Breast Lesion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032) Figure 55. SAMEA Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032) Figure 56. SAMEA Cutting Biopsy System For Breast Lesion Revenue Share by Country (2021-2032) Figure 57. Brazil Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Cutting Biopsy System For Breast Lesion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Half Cut
  • Full Cut
Applications
  • Malignant Breast Tumors
  • Benign Breast Tumors
Companies covered
  • BD
  • Danaher Corporation
  • Cultiva Medical
  • Chongqing Xishan Science & Technology
  • GMT Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cutting Biopsy System For Breast Lesion Market by Type
  3. 1.2.1 Global Cutting Biopsy System For Breast Lesion Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Half Cut
  5. 1.2.3 Full Cut
  6. 1.3 Cutting Biopsy System For Breast Lesion Market by Application
  7. 1.3.1 Global Cutting Biopsy System For Breast Lesion Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Malignant Breast Tumors
  9. 1.3.3 Benign Breast Tumors
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Cutting Biopsy System For Breast Lesion Market Dynamics
  1. 2.1 Cutting Biopsy System For Breast Lesion Industry Trends
  2. 2.2 Cutting Biopsy System For Breast Lesion Industry Drivers
  3. 2.3 Cutting Biopsy System For Breast Lesion Industry Opportunities and Challenges
  4. 2.4 Cutting Biopsy System For Breast Lesion Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cutting Biopsy System For Breast Lesion Market Perspective (2021-2032)
  2. 3.2 Global Cutting Biopsy System For Breast Lesion Growth Trends by Region
  3. 3.2.1 Global Cutting Biopsy System For Breast Lesion Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cutting Biopsy System For Breast Lesion Market Size by Region (2021-2026)
  5. 3.2.3 Global Cutting Biopsy System For Breast Lesion Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cutting Biopsy System For Breast Lesion Revenue by Players
  2. 4.1.1 Global Cutting Biopsy System For Breast Lesion Revenue by Players (2021-2026)
  3. 4.1.2 Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cutting Biopsy System For Breast Lesion Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cutting Biopsy System For Breast Lesion Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cutting Biopsy System For Breast Lesion Key Players Headquarters & Area Served
  7. 4.4 Global Cutting Biopsy System For Breast Lesion Players, Product Type & Application
  8. 4.5 Global Cutting Biopsy System For Breast Lesion Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cutting Biopsy System For Breast Lesion Market CR5 and HHI
  11. 4.6.3 2025 Cutting Biopsy System For Breast Lesion Tier 1, Tier 2, and Tier 3
5 Cutting Biopsy System For Breast Lesion Market Size by Type
  1. 5.1 Global Cutting Biopsy System For Breast Lesion Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2032)
  3. 5.3 Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Type (2021-2032)
6 Cutting Biopsy System For Breast Lesion Market Size by Application
  1. 6.1 Global Cutting Biopsy System For Breast Lesion Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2032)
  3. 6.3 Global Cutting Biopsy System For Breast Lesion Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BD
  2. 7.1.1 BD Company Information
  3. 7.1.2 BD Business Overview
  4. 7.1.3 BD Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BD Cutting Biopsy System For Breast Lesion Product Portfolio
  6. 7.1.5 BD Recent Developments
  7. 7.2 Danaher Corporation
  8. 7.2.1 Danaher Corporation Company Information
  9. 7.2.2 Danaher Corporation Business Overview
  10. 7.2.3 Danaher Corporation Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Danaher Corporation Cutting Biopsy System For Breast Lesion Product Portfolio
  12. 7.2.5 Danaher Corporation Recent Developments
  13. 7.3 Cultiva Medical
  14. 7.3.1 Cultiva Medical Company Information
  15. 7.3.2 Cultiva Medical Business Overview
  16. 7.3.3 Cultiva Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cultiva Medical Cutting Biopsy System For Breast Lesion Product Portfolio
  18. 7.3.5 Cultiva Medical Recent Developments
  19. 7.4 Chongqing Xishan Science & Technology
  20. 7.4.1 Chongqing Xishan Science & Technology Company Information
  21. 7.4.2 Chongqing Xishan Science & Technology Business Overview
  22. 7.4.3 Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Product Portfolio
  24. 7.4.5 Chongqing Xishan Science & Technology Recent Developments
  25. 7.5 GMT Medical
  26. 7.5.1 GMT Medical Company Information
  27. 7.5.2 GMT Medical Business Overview
  28. 7.5.3 GMT Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GMT Medical Cutting Biopsy System For Breast Lesion Product Portfolio
  30. 7.5.5 GMT Medical Recent Developments
8 North America
  1. 8.1 North America Cutting Biopsy System For Breast Lesion Revenue (2021-2032)
  2. 8.2 North America Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2032)
  3. 8.2.1 North America Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026)
  4. 8.2.2 North America Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032)
  5. 8.3 North America Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032)
  6. 8.4 North America Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2032)
  7. 8.4.1 North America Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026)
  8. 8.4.2 North America Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032)
  9. 8.5 North America Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032)
  10. 8.6 North America Cutting Biopsy System For Breast Lesion Revenue by Country
  11. 8.6.1 North America Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026)
  13. 8.6.3 North America Cutting Biopsy System For Breast Lesion Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cutting Biopsy System For Breast Lesion Revenue (2021-2032)
  2. 9.2 Europe Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032)
  5. 9.3 Europe Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032)
  9. 9.5 Europe Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cutting Biopsy System For Breast Lesion Revenue by Country
  11. 9.6.1 Europe Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cutting Biopsy System For Breast Lesion Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cutting Biopsy System For Breast Lesion Revenue (2021-2032)
  2. 10.2 China Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2032)
  3. 10.2.1 China Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026)
  4. 10.2.2 China Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032)
  5. 10.3 China Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032)
  6. 10.4 China Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2032)
  7. 10.4.1 China Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026)
  8. 10.4.2 China Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032)
  9. 10.5 China Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cutting Biopsy System For Breast Lesion Revenue (2021-2032)
  2. 11.2 Asia Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032)
  5. 11.3 Asia Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032)
  9. 11.5 Asia Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cutting Biopsy System For Breast Lesion Revenue by Country
  11. 11.6.1 Asia Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cutting Biopsy System For Breast Lesion Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cutting Biopsy System For Breast Lesion Revenue (2021-2032)
  2. 12.2 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cutting Biopsy System For Breast Lesion Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cutting Biopsy System For Breast Lesion Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country
  11. 12.6.1 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cutting Biopsy System For Breast Lesion Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst